Nitric oxide: what a vascular surgeon needs to know

Area of Science:

• Vascular Surgery
• Biomedical Engineering
• Cardiovascular Research

Background:

• Peripheral arterial disease (PAD) causes significant morbidity and mortality.
• Surgical interventions for PAD, including angioplasty, endarterectomy, and bypass grafting, inherently damage the vascular endothelium.
• Endothelial injury impairs nitric oxide (NO) production, contributing to neointimal hyperplasia and restenosis, which compromise long-term outcomes.

Purpose of the Study:

• To review research focused on enhancing nitric oxide (NO) bioavailability following vascular procedures.
• To explore strategies for improving NO bioavailability to reduce thrombosis and restenosis after revascularization.
• To describe novel NO-releasing products under investigation for clinical application.

Main Methods:

• Review of existing literature on NO bioavailability enhancement strategies.
• Analysis of systemic and local delivery methods for NO.
• Examination of ongoing research into NO-releasing agents for vascular applications.

Main Results:

• Surgical procedures for PAD lead to endothelial dysfunction and reduced NO bioavailability.
• Strategies to improve NO bioavailability are being investigated to mitigate post-procedural complications.
• Various NO-releasing products are in development to improve patency rates and reduce restenosis.

Conclusions:

• Improving NO bioavailability is a critical target for enhancing outcomes after vascular surgery for PAD.
• Both systemic and local delivery approaches show promise in restoring endothelial function and preventing restenosis.
• Emerging NO-releasing technologies offer potential for improved clinical practice in managing vascular disease.